Significant Ownership of Paul B. Manning
- Signature - Title
- /s/ Paul B. Manning - Paul B. Manning
- Location
- Charlottesville, VA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Paul B. Manning.
Follow Filing Activity
Follow Paul B. Manning and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Paul B. Manning
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | Common Stock, $0.0001 par value per share | 50% | $28,437,789 | 8,056,031 | Paul B Manning | 25 Nov 2025 | ||
| TSHA | TAYSHA GENE THERAPIES, INC. | Common Stock, $0.00001 par value per share | 9.8% | $59,394,578 | 25,601,111 | Paul B Manning | 30 May 2025 | ||
| CADL | CANDEL THERAPEUTICS, INC. | Common Stock, $0.01 par value per share | 7.9% | $29,997,375 | 5,790,999 | Paul B Manning | 16 Dec 2024 |
Schedules 13D/G Reported by Paul B. Manning:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.